Abstract
Needle-stick injury (NSI) is a major occupational health and safety issue facing healthcare professionals. The administration of erythropoiesis- stimulating agents (ESA) in haemodialysis patients represents a major cause for injections. The purpose of this initiative was to familiarise nursing staff with needle-free administration of an ESA in haemodialysis patients to reduce the risk of NSI. Epoetin beta comes in a commercial presentation with a detached needle. Epoetin beta was administered to 10 haemodialysis patients via the venous bubble trap short line of the haemodialysis circuit. An audit was conducted that included a retrospective assessment of NSI for the previous six months; and a prospective assessment for eight weeks to assess whether there is a nursing staff preference for needle-free administration of ESA.There were no reports of NSI in the needle-free group. Haemoglobin levels were maintained. Ninety-one percent of the nursing staff preferred needle-free administration of ESA. In conclusion, the commercial presentation of epoetin beta with the detached needle presents an opportunity to reduce the potential risk of NSI in haemodialysis units.
| Original language | English |
|---|---|
| Pages (from-to) | 120-126 |
| Number of pages | 7 |
| Journal | Journal of Renal Care |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Sept 2009 |
| Externally published | Yes |
Keywords
- Anaemia
- Education
- Erythropoiesis-stimulating agents
- Haemodialysis